Murray CJL, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386:2145–91.
Di Pietro NC, Seamans JK. Dopamine and serotonin interactively modulate prefrontal cortex neurons in vitro. Biol Psychiatry. 2011;69:1204–11.
Li Y, Zhou Y, Qi B, Gong T, Sun X, Fu Y, et al. Brain-specific delivery of dopamine mediated by N, N-dimethyl amino group for the treatment of Parkinson’s disease. Mol Pharm. 2014;11:3174–85.
Pardridge WM. Drug targeting to the brain. Pharm Res. 2007;24:1733–44.
Furtado D, Björnmalm M, Ayton S, Bush AI, Kempe K, Caruso F. Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases. Adv Mater. 2018;30:e1801362.
Ballabh P, Braun A, Nedergaard M. The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16:1–13.
Åslund AKO, Berg S, Hak S, Mørch Ý, Torp SH, Sandvig A, et al. Nanoparticle delivery to the brain—by focused ultrasound and self-assembled nanoparticle-stabilized microbubbles. J Control Release. 2015;220:87–94.
Ligade CP, Jadhav RK, Kadam JV. Brain drug delivery system: an overview. Curr Drug Ther. 2010;5:105–10.
Gao W, Liu Y, Jing G, Li K, Zhao Y, Sha B, et al. Rapid and efficient crossing blood–brain barrier: Hydrophobic drug delivery system based on propionylated amylose helix nanoclusters. Biomaterials. 2017;113:133–44.
Fan CH, Chang EL, Ting CY, Lin YC, Liao EC, Huang CY, et al. Folate-conjugated gene-carrying microbubbles with focused ultrasound for concurrent blood–brain barrier opening and local gene delivery. Biomaterials. 2016;106:46–57.
Li X, Tsibouklis J, Weng T, Zhang B, Yin G, Feng G, et al. Nano carriers for drug transport across the blood–brain barrier. J Drug Target. 2017;25:17–28.
Endo-Takahashi Y, Kurokawa R, Sato K, Takizawa N, Katagiri F, Hamano N, et al. Ternary complexes of pdna, neuron-binding peptide, and pegylated polyethyleneimine for brain delivery with nano-bubbles and ultrasound. Pharmaceutics. 2021;13:1003.
Pan M, Zhang Y, Deng Z, Yan F, Hong G. Noninvasive and local delivery of adenoviral-mediated herpes simplex virus thymidine kinase to treat glioma through focused ultrasound-induced blood–brain barrier opening in rats. J Biomed Nanotechnol. 2018;14:2031–41.
Bakay L, Hueter TF, Ballantine HT, Sosa D. Ultrasonically produced changes in the blood–brain barrier. Arch Neurol Psychiatry. 1956;76:457–67.
Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Non-invasive opening of BBB by focused ultrasound. Acta Neurochir. 2003;Suppl 86:555–8.
Izadifar Z, Babyn P, Chapman D. Ultrasound cavitation/microbubble detection and medical applications. J Med Biol Eng. 2019;39:259–76.
Li J, Xi A, Qiao H, Liu Z. Ultrasound-mediated diagnostic imaging and advanced treatment with multifunctional micro/nanobubbles. Cancer Lett. 2020;475:92–8.
Yaqiong LP, Ruiqing LM, Shaobo DM, Lianzhong ZM. Advances in targeted tumor diagnosis and therapy based on ultrasound-responsive nanodroplets. Adv Ultrasound Diagn Therapy. 2020;4:273–83.
Du ZJ, Bi GQ, Cui XT. Electrically controlled neurochemical release from dual-layer conducting polymer films for precise modulation of neural network activity in rat barrel cortex. Adv Funct Mater. 2018;28:1703988.
Weaver CL, Larosa JM, Luo X, Cui XT. Electrically controlled drug delivery from graphene oxide nanocomposite films. ACS Nano. 2014;8:1834–43.
Yu G, Yu W, Mao Z, Gao C, Huang F. A pillararene-based ternary drug-delivery system with photocontrolled anticancer drug release. Small. 2015;11:919–25.
Dai Y, Bi H, Deng X, Li C, He F, Ma P, et al. 808 nm near-infrared light controlled dual-drug release and cancer therapy in vivo by upconversion mesoporous silica nanostructures. J Mater Chem B. 2017;5:2086–95.
Barbosa J, Correia DM, Gonçalves R, Ribeiro C, Botelho G, Martins P, et al. Magnetically controlled drug release system through magnetomechanical actuation. Adv Healthc Mater. 2016;5:3027–34.
Norris MD, Seidel K, Kirschning A. Externally induced drug release systems with magnetic nanoparticle carriers: an emerging field in nanomedicine. Adv Ther. 2019;2:1800092.
Tung Y-S, Vlachos F, Feshitan JA, Borden MA, Konofagou EE. The mechanism of interaction between focused ultrasound and microbubbles in blood–brain barrier opening in mice. J Acoust Soc Am. 2011;130:3059–67.
McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS. Temporary disruption of the blood–brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012;72:3652–63.
Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, Masellis M, et al. Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound. Nat Commun. 2018;9:4373.
Cool SK, Geers B, Roels S, Stremersch S, Vanderperren K, Saunders JH, et al. Coupling of drug containing liposomes to microbubbles improves ultrasound triggered drug delivery in mice. J Controlled Release. 2013;172:885–93.
Ninomiya K, Yamashita T, Kawabata S, Shimizu N. Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer. Ultrason Sonochem. 2014;21:1482–8.
Alford A, Rich M, Kozlovskaya V, Chen J, Sherwood J, Bolding M, et al. Ultrasound-triggered delivery of anticancer therapeutics from mri-visible multilayer microcapsules. Adv Ther. 2018;1:1800051.
Li P, Zheng Y, Ran H, Tan J, Lin Y, Zhang Q, et al. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice. J Controlled Release. 2012;162:349–54.
Cao Y, Chen Y, Yu T, Guo Y, Liu F, Yao Y, et al. Drug release from phase-changeable nanodroplets triggered by low-intensity focused ultrasound. Theranostics. 2018;8:127.
Jiang X, Savchenko O, Li Y, Qi S, Yang T, Zhang W, et al. A review of low-intensity pulsed ultrasound for therapeutic applications. IEEE Trans Biomed Eng. 2019;66:1327–39.
Malizos KN, Hantes ME, Protopappas V, Papachristos A. Low-intensity pulsed ultrasound for bone healing: an overview. Injury. 2006;37:S56–62.
Newman PG, Rozycki GS. The history of ultrasound. Surg Clin N Am. 1998;78:179–95.
Rezai AR, Ranjan M, D’Haese PF, Haut MW, Carpenter J, Najib U, et al. Noninvasive hippocampal blood−brain barrier opening in Alzheimer’s disease with focused ultrasound. Proc Natl Acad Sci U S A. 2020;117:9180–2.
Leinenga G, Langton C, Nisbet R, Götz J. Ultrasound treatment of neurological diseases-current and emerging applications. Nat Rev Neurosci. 2016;12:161–74.
Chen KT, Chai WY, Lin YJ, Lin CJ, Chen PY, Tsai HC, et al. Neuronavigation-guided focused ultrasound for transcranial blood–brain barrier opening and immunostimulation in brain tumors. Sci Adv. 2021;7:eabd772.
Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. Local and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage. 2005;24:12–20.
Shin J, Kong C, Cho JS, Lee J, Koh CS, Yoon MS, et al. Focused ultrasound-mediated noninvasive blood–brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters. Neurosurg Focus. 2018;44:E15.
McDannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood–brain barrier disruption. Ultrasound Med Biol. 2008;34:930–7.
Fan CH, Ting CY, Chang YC, Wei KC, Liu HL, Yeh CK. Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood–brain barrier opening and brain-tumor drug delivery. Acta Biomater. 2015;15:89–101.
Fan CH, Lin HJ, Ting CY, Liu HL, Yen TC, Yeh CK. Superparamagnetic iron-oxide drug-loading microbubbles for concurrent magnetic resonance imaging monitoring and focused-ultrasound enhanced brain-tumor drug delivery. IEEE Int Ultrason Symp, IUS. 2012;2274–7.
Chen CC, Sheeran PS, Wu SY, Olumolade OO, Dayton PA, Konofagou EE. Targeted drug delivery with focused ultrasound-induced blood–brain barrier opening using acoustically-activated nanodroplets. J Controlled Release. 2013;172:795–804.
Zhang X, Hu J, Zhao G, Huang N, Tan Y, Pi L, et al. PEGylated PLGA-based phase shift nanodroplets combined with focused ultrasound for blood–brain barrier opening in rats. Oncotarget. 2017;8:38927.
Cheng B, Bing C, Xi Y, Shah B, Exner AA, Chopra R. Influence of nanobubble concentration on blood–brain barrier opening using focused ultrasound under real-time acoustic feedback control. Ultrasound Med Biol. 2019;45:2174–87.
Zhang DY, Dmello C, Chen L, Arrieta VA, Gonzalez-Buendia E, Robert Kane J, et al. Ultrasound-mediated delivery of paclitaxel for glioma: a comparative study of distribution, toxicity, and efficacy of albumin-bound versus cremophor formulations. Clin Cancer Res. 2020;26:477–86.
Airan RD, Meyer RA, Ellens NPK, Rhodes KR, Farahani K, Pomper MG, et al. Noninvasive targeted transcranial neuromodulation via focused ultrasound gated drug release from nanoemulsions. Nano Lett. 2017;17:652–9.
Park J, Zhang Y, Vykhodtseva N, Jolesz FA, McDannold NJ. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. J Controlled Release. 2012;162:134–42.
Yang FY, Wong TT, Teng MC, Liu RS, Lu M, Liang HF, et al. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Controlled Release. 2012;160:652–8.
Timbie KF, Afzal U, Date A, Zhang C, Song J, Wilson Miller G, et al. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound. J Controlled Release. 2017;263:120–31.
Papachristodoulou A, Signorell RD, Werner B, Brambilla D, Luciani P, Cavusoglu M, et al. Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes. J Controlled Release. 2019;295:130–9.
Ting CY, Fan CH, Liu HL, Huang CY, Hsieh HY, Yen TC, et al. Concurrent blood–brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials. 2012;33:704–12.
Lin CY, Tsai CH, Feng LY, Chai WY, Lin CJ, Huang CY, et al. Focused ultrasound-induced blood brain-barrier opening enhanced vascular permeability for GDNF delivery in Huntington’s disease mouse model. Brain Stimul. 2019;12:1143–50.
Kovacs Z, Werner B, Rassi A, Sass JO, Martin-Fiori E, Bernasconi M. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J Controlled Release. 2014;187:74–82.
Rich MC, Sherwood J, Bartley AF, Whitsitt QA, Lee M, Willoughby WR, et al. Focused ultrasound blood brain barrier opening mediated delivery of MRI-visible albumin nanoclusters to the rat brain for localized drug delivery with temporal control. J Controlled Release. 2020;324:172–80.
Tharkar P, Varanasi R, Wong WSF, Jin CT, Chrzanowski W. Nano-enhanced drug delivery and therapeutic ultrasound for cancer treatment and beyond. Front Bioeng Biotechnol. 2019;7:324.
Brotchie A, Grieser F, Ashokkumar M. Effect of power and frequency on bubble-size distributions in acoustic cavitation. Phys Rev Lett. 2009;102: 084302.
Ashokkumar M. The characterization of acoustic cavitation bubbles—an overview. Ultrason Sonochem. 2011;18:864–72.
Dalecki D. Mechanical bioeffects of ultrasound. Annu Rev Biomed Eng. 2004;6:229–48.
Chowdhury SM, Abou-Elkacem L, Lee T, Dahl J, Lutz AM. Ultrasound and microbubble mediated therapeutic delivery: underlying mechanisms and future outlook. J Controlled Release. 2020;326:75–90.
Meairs S, Alonso A. Ultrasound, microbubbles and the blood–brain barrier. Prog Biophys Mol Biol. 2007;93:354–62.
Dasgupta A, Liu M, Ojha T, Storm G, Kiessling F, Lammers T. Ultrasound-mediated drug delivery to the brain: principles, progress and prospects. Drug Discov Today: Technol. 2016;20:41–8.
Baseri B, Choi JJ, Tung YS, Konofagou EE. Multi-modality safety assessment of blood–brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. Ultrasound Med Biol. 2010;36:1445–59.
Klotz AR, Lindvere L, Stefanovic B, Hynynen K. Temperature change near microbubbles within a capillary network during focused ultrasound. Phys Med Biol. 2010;55:1549–61.
Vernès L, Vian M, Chemat F. Ultrasound and microwave as green tools for solid-liquid extraction. In: Poole CF, editor. Liquid-phase extraction. Elsevier; 2020. p. 355–74.
Sviridov AP, Osminkina LA, Nikolaev AL, Kudryavtsev AA, Vasiliev AN, Timoshenko VY. Lowering of the cavitation threshold in aqueous suspensions of porous silicon nanoparticles for sonodynamic therapy applications. Appl Phys Lett. 2015;107: 123107.
Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G. New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv. 2009;6:1017–32.
Zhou Y, Peng Z, Seven ES, Leblanc RM. Crossing the blood–brain barrier with nanoparticles. J Controlled Release. 2018;270:290–303.
Kim SS, Harford JB, Pirollo KF, Chang EH. Effective treatment of glioblastoma requires crossing the blood–brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine. Biochem Biophys Res Commun. 2015;468:485–9.
Ahmadi A, Hosseini-Nami S, Abed Z, Beik J, Aranda-Lara L, Samadian H, et al. Recent advances in ultrasound-triggered drug delivery through lipid-based nanomaterials. Drug Discov Today. 2020;25:2182–200.
Tsou YH, Zhang XQ, Zhu H, Syed S, Xu X. Drug delivery to the brain across the blood–brain barrier using nanomaterials. Small. 2017;13:1701921.
Xie J, Shen Z, Anraku Y, Kataoka K, Chen X. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials. 2019;224: 119491.
Yang FY, Teng MC, Lu M, Liang HF, Lee YR, Yen CC, et al. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound. Int J Nanomedicine. 2012;7:965–74.
Wang X, Liu P, Yang W, Li L, Li P, Liu Z, et al. Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier. Int J Nanomed. 2014;9:4899–909.
Yang FY, Horng SC. Chemotherapy of glioblastoma by targeted liposomal platinum compounds with focused ultrasound. Proceedings of the annual international conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2013;6289–92.
Chonpathompikunlert P, Fan CH, Ozaki Y, Yoshitomi T, Yeh CK, Nagasaki Y. Redox nanoparticle treatment protects against neurological deficit in focused ultrasound-induced intracerebral hemorrhage. Nanomedicine (Lond). 2012;7:1029–43.
Guo Y, Lee H, Fang Z, Velalopoulou A, Kim J, Ben TM, et al. Single-cell analysis reveals effective siRNA delivery in brain tumors with microbubble-enhanced ultrasound and cationic nanoparticles. Sci Adv. 2021;7:eabf7390.
Chen PY, Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, et al. Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol. 2010;12:1050–60.
Baghirov H, Snipstad S, Sulheim E, Berg S, Hansen R, Thorsen F, et al. Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model. PLoS ONE. 2018;13: e0191102.
Yao L, Song Q, Bai W, Zhang J, Miao D, Jiang M, et al. Facilitated brain delivery of poly (ethylene glycol)-poly (lactic acid) nanoparticles by microbubble-enhanced unfocused ultrasound. Biomaterials. 2014;35:3384–95.
Curley CT, Mead BP, Negron K, Kim N, Garrison WJ, Wilson Miller G, et al. Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection. Sci Adv. 2020;6:eaay1344.
Coluccia D, Figueiredo CA, Wu MYJ, Riemenschneider AN, Diaz R, Luck A, et al. Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound. Nanomedicine. 2018;14:1137–48.
Rehman FU, Rauf MA, Ullah S, Shaikh S, Qambrani A, Muhammad P, et al. Ultrasound-activated nano-TiO2 loaded with temozolomide paves the way for resection of chemoresistant glioblastoma multiforme. Cancer Nanotechnol. 2021;12:1–17.
Wang Y, Luo S, Wu Y, Tang P, Liu J, Liu Z, et al. Highly penetrable and on-demand oxygen release with tumor activity composite nanosystem for photothermal/photodynamic synergetic therapy. ACS Nano. 2020;14:17046–62.
Luo S, Wang Y, Shen S, Tang P, Liu Z, Zhang S, et al. IR780-loaded hyaluronic Acid@Gossypol–Fe(III)–EGCG infinite coordination polymer nanoparticles for highly efficient tumor photothermal/coordinated dual drugs synergistic therapy. Adv Funct Mater. 2021;31:2100954.
Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, Dehouck MP, et al. Modelling of the blood–brain barrier in drug discovery and development. Nat Rev Drug Discov. 2007;6:650–61.
Liu Y, Paliwal S, Bankiewicz KS, Bringas JR, Heart G, Mitragotri S, et al. Ultrasound-enhanced drug transport and distribution in the brain. AAPS PharmSciTech. 2010;11:1005–17.
O’Reilly MA, Hynynen K. Ultrasound enhanced drug delivery to the brain and central nervous system. Int J Hyperth. 2012;28:386–96.
Meairs S. Facilitation of drug transport across the blood–brain barrier with ultrasound and microbubbles. Pharmaceutics. 2015;7:275–93.
Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer. 2007;121:901–7.
Sun T, Zhang Y, Power C, Alexander PM, Sutton JT, Aryal M, et al. Closed-loop control of targeted ultrasound drug delivery across the blood–brain/tumor barriers in a rat glioma model. Proc Natl Acad Sci U S A. 2017;114:E10281–90.
Liu Y, Gong Y, Xie W, Huang A, Yuan X, Zhou H, et al. Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer’s disease. Nanoscale. 2020;12:6498–511.
Oikari LE, Pandit R, Stewart R, Cuní-López C, Quek H, Sutharsan R, et al. Altered brain endothelial cell phenotype from a familial Alzheimer mutation and its potential implications for amyloid clearance and drug delivery. Stem Cell Rep. 2020;14:924–39.
Bzyl J, Lederle W, Rix A, Grouls C, Tardy I, Pochon S, et al. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol. 2011;21:1988–95.
Unnikrishnan S, Klibanov AL. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. AJR Am J Roentgenol. 2012;199:292–9.
Barak M, Katz Y. Microbubbles: pathophysiology and clinical implications. Chest. 2005;128:2918–32.
Endo-Takahashi Y, Negishi Y. Microbubbles and nanobubbles with ultrasound for systemic gene delivery. Pharmaceutics. 2020;12:964.
Cavalli R, Soster M, Argenziano M. Nanobubbles: a promising efficient tool for therapeutic delivery. Ther Deliv. 2016;7:117–38.
Bin CW, Yang HL, Zhang J, Yin JK, Yang YL, Yuan LJ, et al. The optimized fabrication of nanobubbles as ultrasound contrast agents for tumor imaging. Sci Rep. 2015;5:1–11.
Lamsam L, Johnson E, Connolly ID, Wintermark M, Gephart MH. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy. Neurosurg Focus. 2018;44:E10.
Beccaria K, Sabbagh A, de Groot J, Canney M, Carpentier A, Heimberger AB. Blood–brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors. J Neurooncol. 2021;151:65–73.
Lee JY, Carugo D, Crake C, Owen J, De Saint VM, Seth A, et al. Nanoparticle-loaded protein-polymer nanodroplets for improved stability and conversion efficiency in ultrasound imaging and drug delivery. Adv Mater. 2015;27:5484–92.
Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B. 2016;6:268–86.
Rapoport N. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer. Wiley Interdiscip Rev Comput Mol Sci. 2012;4:492–510.
Rapoport NY, Efros AL, Christensen DA, Kennedy AM, Nam KH. Microbubble generation in phase-shift nanoemulsions used as anticancer drug carriers. Bubble Sci Eng Technol. 2009;1:31–9.
Fabiilli ML, Haworth KJ, Fakhri NH, Kripfgans OD, Carson PL, Fowlkes JB. The role of inertial cavitation in acoustic droplet vaporization. IEEE Trans Ultrason Ferroelectr Freq Control. 2009;56:1006–17.
Rapoport N. Drug-loaded perfluorocarbon nanodroplets for ultrasound-mediated drug delivery. Adv Exp Med Biol. 2016;880:221–41.
Wang Y, Li X, Zhou Y, Huang P, Xu Y. Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. Int J Pharm. 2010;384:148–53.
Sheng D, Deng L, Li P, Wang Z, Zhang Q. Perfluorocarbon nanodroplets with deep tumor penetration and controlled drug delivery for ultrasound/fluorescence imaging guided breast cancer therapy. ACS Biomater Sci Eng. 2021;7:605–16.
Sierra C, Acosta C, Chen C, Wu SY, Karakatsani ME, Bernal M, et al. Lipid microbubbles as a vehicle for targeted drug delivery using focused ultrasound-induced blood–brain barrier opening. J Cereb Blood Flow Metab. 2017;37:1236–50.
Abrahao A, Meng Y, Llinas M, Huang Y, Hamani C, Mainprize T, et al. First-in-human trial of blood–brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound. Nat Commun. 2019;10:1–9.
Nance E, Timbie K, Miller GW, Song J, Louttit C, Klibanov AL, et al. Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood–brain barrier using MRI-guided focused ultrasound. J Control Release. 2014;189:123–32.
Wu P, Zhu M, Li Y, Ya Z, Yang Y, Yuan Y, et al. Cascade-amplifying synergistic therapy for intracranial glioma via endogenous reactive oxygen species-triggered “all-in-one” nanoplatform. Adv Funct Mater. 2021;31:2105786.
Fisher DG, Price RJ. Recent advances in the use of focused ultrasound for magnetic resonance image-guided therapeutic nanoparticle delivery to the central nervous system. Front Pharmacol. 2019;10:1348.
Stride E, Edirisinghe M. Novel microbubble preparation technologies. Soft Matter. 2008;4:2350–9.
Xi X-P, Zong Y-J, Ji Y-H, Wang B, Liu H-S. Experiment research of focused ultrasound combined with drug and microbubble for treatment of central nervous system leukemia. Oncotarget. 2018;9:5424–34.
Barbu E, Molnàr É, Tsibouklis J, Górecki DC. The potential for nanoparticle-based drug delivery to the brain: Overcoming the blood–brain barrier. Expert Opin Drug Deliv. 2009;6:553–65.
Lalatsa A, Leite DM, Figueiredo MF, O’Connor M. Nanotechnology in brain tumor targeting: efficacy and safety of nanoenabled carriers undergoing clinical testing. Nanotechnology-based targeted drug delivery systems for brain tumors. Academic Press. 2018; pp 111–45.
Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K. Improved anti-tumor effect of liposomal doxorubicin after targeted blood–brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol. 2012;38:1716–25.
Etame AB, Diaz RJ, O’Reilly MA, Smith CA, Mainprize TG, Hynynen K, et al. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine. 2012;8:1133–42.
Huang HY, Liu HL, Hsu PH, Chiang CS, Tsai CH, Chi HS, et al. A multitheragnostic nanobubble system to induce blood–brain barrier disruption with magnetically guided focused ultrasound. Adv Mater. 2015;27:655–61.
Cheng CL, Chan MH, Feng SJ, Hsiao M, Liu RS. Long-term near-infrared signal tracking of the therapeutic changes of glioblastoma cells in brain tissue with ultrasound-guided persistent luminescent nanocomposites. ACS Appl Mater Interfaces. 2021;13:6099–108.
Lin Q, Mao KL, Tian FR, Yang JJ, Chen PP, Xu J, et al. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes. Cancer Chemother Pharmacol. 2016;77:269–80.
Shen Y, Pi Z, Yan F, Yeh CK, Zeng X, Diao X, et al. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts. Int J Nanomedicine. 2017;12:5613–29.
Liao AH, Liu HL, Su CH, Hua MY, Yang HW, Weng YT, et al. Paramagnetic perfluorocarbon-filled albumin-(Gd-DTPA) microbubbles for the induction of focused-ultrasound-induced bloodbrain barrier opening and concurrent MR and ultrasound imaging. Phys Med Biol. 2012;57:2787–802.
Aryal M, Park J, Vykhodtseva N, Zhang YZ, McDannold N. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: Evaluation during tumor progression in a rat glioma model. Phys Med Biol. 2015;60:2511–27.
Yang Q, Zhou Y, Chen J, Huang N, Wang Z, Cheng Y. Gene therapy for drug-resistant glioblastoma via lipid-polymer hybrid nanoparticles combined with focused ultrasound. Int J Nanomed. 2021;16:185–99.
Wu SY, Fix SM, Arena CB, Chen CC, Zheng W, Olumolade OO, et al. Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery. Phys Med Biol. 2018;63: 035002.
Gao D, Xu M, Cao Z, Gao J, Chen Y, Li Y, et al. Ultrasound-triggered phase-transition cationic nanodroplets for enhanced gene delivery. ACS Appl Mater Interfaces. 2015;7:13524–37.
Meng D, Guo L, Shi D, Sun X, Shang M, Zhou X, et al. Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery. Nanomedicine. 2019;14:2549–65.
Fan CH, Ting CY, Liu HL, Huang CY, Hsieh HY, Yen TC, et al. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials. 2013;34:2142–55.
Ishida J, Alli S, Bondoc A, Golbourn B, Sabha N, Mikloska K, et al. MRI-guided focused ultrasound enhances drug delivery in experimental diffuse intrinsic pontine glioma. J Controlled Release. 2021;330:1034–45.
Li Y, Wu M, Zhang N, Tang C, Jiang P, Liu X, et al. Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound. J Cell Mol Med. 2018;22:4171–82.
Liu HL, Hua MY, Yang HW, Huang CY, Chu PN, Wu JS, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. PNAS. 2010;107:15205–10.
Deng Z, Sheng Z, Yan F. Ultrasound-induced blood-brain-barrier opening enhances anticancer efficacy in the treatment of glioblastoma: current status and future Prospects. J Oncol. 2019;2019:2345203.
Chen KT, Wei KC, Liu HL. Theranostic strategy of focused ultrasound induced blood–brain barrier opening for CNS disease treatment. Front Pharmacol. 2019;10:86.
Wei KC, Chu PC, Wang HYJ, Huang CY, Chen PY, Tsai HC, et al. Focused ultrasound-induced blood–brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study. PLoS ONE. 2013;8: e58995.
Etame AB, Diaz RJ, Smith CA, Mainprize TG, Hynynen K, Rutka JT. Focused ultrasound disruption of the blood–brain barrier: a new frontier for therapeutic delivery in molecular neurooncology. Neurosurg Focus. 2012;32:E3.
Wu M, Chen W, Chen Y, Zhang H, Liu C, Deng Z, et al. Focused ultrasound-augmented delivery of biodegradable multifunctional nanoplatforms for imaging-guided brain tumor treatment. Adv Sci. 2018;5:1700474.
Chan MH, Chen W, Li CH, Fang CY, Chang YC, Wei DH, et al. An advanced in situ magnetic resonance imaging and ultrasonic theranostics nanocomposite platform: crossing the blood–brain barrier and improving the suppression of glioblastoma using iron-platinum nanoparticles in nanobubbles. ACS Appl Mater Interfaces. 2021;13:26759–69.
Zhang L, Yi H, Song J, Huang J, Yang K, Tan B, et al. Mitochondria-targeted and ultrasound-activated nanodroplets for enhanced deep-penetration sonodynamic cancer therapy. ACS Appl Mater Interfaces. 2019;11:9355–66.
Mead BP, Kim N, Miller GW, Hodges D, Mastorakos P, Klibanov AL, et al. Novel focused ultrasound gene therapy approach noninvasively restores dopaminergic neuron function in a rat Parkinson’s disease model. Nano Lett. 2017;17:3533–42.
Lea-Banks H, Meng Y, Wu SK, Belhadjhamida R, Hamani C, Hynynen K. Ultrasound-sensitive nanodroplets achieve targeted neuromodulation. J Control Release. 2021;332:30–9.
Fateh ST, Moradi L, Kohan E, Hamblin MR, Dezfuli AS. Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications. Beilstein J Nanotechnol. 2021;12:808–62.
Chen K-T, Lin Y-J, Chai W-Y, Lin C-J, Chen P-Y, Huang C-Y, et al. Neuronavigation-guided focused ultrasound (NaviFUS) for transcranial blood–brain barrier opening in recurrent glioblastoma patients: clinical trial protocol. Ann Transl Med. 2020;8.
Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, Horodyckid C, et al. Clinical trial of blood–brain barrier disruption by pulsed ultrasound. Sci Transl Med. 2016;8:343re2.
Dréan A, Lemaire N, Bouchoux G, Goldwirt L, Canney M, Goli L, et al. Temporary blood–brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma. J Neurooncol. 2019;144:33–41.
Idbaih A, Canney M, Belin L, Desseaux C, Vignot A, Bouchoux G, et al. Safety and feasibility of repeated and transient blood–brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma. Clin Cancer Res. 2019;25:3793–801.
Ferri S, Wu Q, De Grazia A, Polydorou A, May JP, Stride E, et al. Tailoring the size of ultrasound responsive lipid-shelled nanodroplets by varying production parameters and environmental conditions. Ultrason Sonochem. 2021;73: 105482.
Zhang S, Zhang S, Luo S, Wu D. Therapeutic agent-based infinite coordination polymer nanomedicines for tumor therapy. Coord Chem Rev. 2021;445: 214059.
Liu Y, Gao H, Hu Q, An P. Experimental study on targeting brain tumor with ultrasound nanoparticles across blood brain barrier. Nanosci Nanotechnol Lett. 2020;12:543–9.
D'Arrigo J S. Targeting nanotherapy for Alzheimer's disease in human brain: transcranial-ultrasound sonoporation augmenting receptor-mediated drug delivery.